{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:33:26Z","timestamp":1784331206583,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.autrev.2011.05.022","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T07:48:03Z","timestamp":1308901683000},"page":"773-778","source":"Crossref","is-referenced-by-count":75,"title":["Atherosclerosis in psoriatic arthritis"],"prefix":"10.1016","volume":"10","author":[{"given":"R.","family":"Ramonda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lo Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Modesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nalotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Musacchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Iaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Punzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2011.05.022_bb0005","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1161\/CIRCULATIONAHA.104.507996","article-title":"Accelerated atherosclerosis in autoimmune rheumatic diseases","volume":"112","author":"Shoenfeld","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2011.05.022_bb0010","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/ard.62.11.1071","article-title":"Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus","volume":"62","author":"Doria","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.05.022_bb0015","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.autrev.2009.02.015","article-title":"Cardiovascular risk in rheumatoid arthritis","volume":"8","author":"Nurmohamed","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.022_bb0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2008.08.004","article-title":"Cardiovascular involvement in systemic autoimmune diseases","volume":"8","author":"Sitia","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.022_bb0025","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.autrev.2010.08.002","article-title":"Cardiac involvement in systemic rheumatic diseases: an update","volume":"9","author":"Sarzi-Puttini","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.022_bb0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.autrev.2010.09.014","article-title":"Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality","volume":"10","author":"Nussinovitch","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.022_bb0035","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/art.24014","article-title":"Subclinical carotid atherosclerosis in patients with psoriatic arthritis","volume":"59","author":"Tam","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.05.022_bb0040","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.autrev.2010.05.018","article-title":"Endothelial dysfunction and vascular stiffness in systemic lupus erythematosus: are they early markers of subclinical atherosclerosis?","volume":"9","author":"Zardi","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.022_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis \u2014 an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2011.05.022_bb0050","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.autrev.2010.07.016","article-title":"From endothelial dysfunction to atherosclerosis","volume":"9","author":"Sitia","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.022_bb0055","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.autrev.2010.06.001","article-title":"How early is the atherosclerotic risk in rheumatoid arthritis?","volume":"9","author":"Bartoloni","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.022_bb0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12016-008-8098-6","article-title":"Pentraxins, anti-pentraxin antibodies, and atherosclerosis","volume":"37","author":"Bassi","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2011.05.022_bb0065","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2011.05.022_bb0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.rdc.2005.01.006","article-title":"Inflammation and accelerated atherosclerosis-basic mechanisms","volume":"31","author":"Doria","year":"2005","journal-title":"Rheum Dis Clin N Am"},{"issue":"1","key":"10.1016\/j.autrev.2011.05.022_bb0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.autrev.2007.06.003","article-title":"OxLDL\/\u03b22GPI-anti-oxLDL\/\u03b22GPI complex and atherosclerosis in SLE patients","volume":"7","author":"Bassi","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.022_bb0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.autrev.2009.03.001","article-title":"The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis","volume":"9","author":"van Leeuwen","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.022_bb0085","first-page":"179","article-title":"Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules","volume":"13","author":"Del Papa","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.05.022_bb0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/08916930903374527","article-title":"Atherosclerosis in systemic lupus erythematosus","volume":"43","author":"Sherer","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2011.05.022_bb0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.autrev.2008.12.004","article-title":"Heat-shock proteins can promote as well as regulate autoimmunity","volume":"8","author":"Rajaiah","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.022_bb0100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0140-6736(93)92613-X","article-title":"Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis","volume":"341","author":"Xu","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2011.05.022_bb0105","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0735-1097(01)01440-1","article-title":"Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice","volume":"38","author":"George","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2011.05.022_bb0110","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/hc0502.103348","article-title":"T-cell-mediated lysis of endothelial cells in acute coronary syndromes","volume":"105","author":"Nakajima","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2011.05.022_bb0115","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1161\/01.CIR.0000131450.66017.B3","article-title":"CD4+ CD28\u2212 T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients","volume":"109","author":"Gerli","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2011.05.022_bb0120","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/01.CIR.101.25.2883","article-title":"Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes","volume":"101","author":"Liuzzo","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2011.05.022_bb0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-3083.1999.00559.x","article-title":"Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice","volume":"50","author":"Zhou","year":"1999","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2011.05.022_bb0130","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.109.868158","article-title":"Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"120","author":"Lewis","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2011.05.022_bb0135","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2011.05.022_bb0140","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.ATV.0000143933.20616.1b","article-title":"Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice","volume":"24","author":"Branen","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2011.05.022_bb0145","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.autrev.2009.01.012","article-title":"Interleukin-6 as a key player in systemic inflammation and joint destruction","volume":"8","author":"Fonseca","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.022_bb0150","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jbspin.2008.03.004","article-title":"Interleukin 23: a key cytokine in chronic inflammatory diseases","volume":"75","author":"Wendling","year":"2008","journal-title":"Joint Bone Spine"},{"issue":"Suppl 2","key":"10.1016\/j.autrev.2011.05.022_bb0155","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar1917","article-title":"Interleukin-6 and chronic inflammation","volume":"8","author":"Gabay","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.05.022_bb0160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1160\/TH09-05-0297","article-title":"How much is too much? Interleukin-6 and its signalling in atherosclerosis","volume":"102","author":"Schuett","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2011.05.022_bb0165","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.autrev.2010.07.003","article-title":"Abu El-Saad AM, Krieger T, Conrad K, et al. Interleukin-17-producing T helper cells in autoimmunity","volume":"9","author":"Hemdan","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.022_bb0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00712.x","article-title":"Th17 cytokines and their emerging roles in inflammation and autoimmunity","volume":"226","author":"Fouser","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2011.05.022_bb0175","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/01.mca.0000236288.94553.b4","article-title":"Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease","volume":"17","author":"Hashmi","year":"2006","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.autrev.2011.05.022_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.atherosclerosis.2008.11.022","article-title":"Interleukin 17: an unlikely marker of acute coronary syndrome?","volume":"205","author":"Patel","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2011.05.022_bb0185","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/jb\/mvq043","article-title":"Cellular and molecular basis for the regulation of inflammation by TGF-beta","volume":"147","author":"Yoshimura","year":"2010","journal-title":"J Biochem"},{"key":"10.1016\/j.autrev.2011.05.022_bb0190","first-page":"1189","article-title":"TNF alpha down-regulates CD105 expression in vascular endothelial cells: a comparative study with TGF beta 1","volume":"23","author":"Li","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.autrev.2011.05.022_bb0195","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1172\/JCI18607","article-title":"Disruption of TGF-beta signalling in T-cells accelerates atherosclerosis","volume":"112","author":"Robertson","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2011.05.022_bb0200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF03402102","article-title":"Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice","volume":"9","author":"Caligiuri","year":"2003","journal-title":"Mol Med"},{"key":"10.1016\/j.autrev.2011.05.022_bb0205","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.semarthrit.2004.07.010","article-title":"Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis","volume":"34","author":"Peters","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl 1","key":"10.1016\/j.autrev.2011.05.022_bb0210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/ard.2010.140582","article-title":"Psoriatic arthritis: update on pathophysiology, assessment and management","volume":"70","author":"Mease","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.05.022_bb0215","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.autrev.2006.12.003","article-title":"Pathogenetic and clinical rationale for TNF-blocking therapy in psoriatic arthritis","volume":"6","author":"Punzi","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.022_bb0220","first-page":"260","article-title":"Angiopoietins, growth factors, and vascular morphology in early arthritis","volume":"30","author":"Fearon","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.05.022_bb0225","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/07853890802516507","article-title":"Atherosclerotic plaque development and instability: a dual role for VEGF","volume":"41","author":"Holm","year":"2009","journal-title":"Ann Med"},{"key":"10.1016\/j.autrev.2011.05.022_bb0230","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nm0307-242","article-title":"Cracking the cytokine code in psoriasis","volume":"3","author":"Nickoloff","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2011.05.022_bb0235","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/ard.2009.107649","article-title":"Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis","volume":"69","author":"Melis","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.05.022_bb0240","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/art.1780401021","article-title":"Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death","volume":"40","author":"Wong","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.05.022_bb0245","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.05.022_bb0250","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/acr.20363","article-title":"Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis","volume":"63","author":"Mok","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2011.05.022_bb0255","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clnu.2004.08.004","article-title":"Dyslipidemia and inflammation: an evolutionary conserved mechanism","volume":"24","author":"Esteve","year":"2005","journal-title":"Clin Nutr"},{"key":"10.1016\/j.autrev.2011.05.022_bb0260","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/ard.59.11.904","article-title":"Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease","volume":"59","author":"Jones","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.05.022_bb0265","first-page":"79","article-title":"Apolipoprotein A-I and cholesterol in synovial fluid of patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis","volume":"27","author":"Oliviero","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.05.022_bb0270","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2133.2007.08068.x","article-title":"Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review","volume":"157","author":"Sterry","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2011.05.022_bb0275","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1365-2133.2008.08759.x","article-title":"Clear differences in adiponectin level and glutathione redox status revealed in obese and normal-weight patients with psoriasis","volume":"159","author":"Kaur","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2011.05.022_bb0280","doi-asserted-by":"crossref","unstructured":"Kaur S, Zilmer K, Leping V, Zilmer M. The levels of adiponectin and leptin and their relation to other markers of cardiovascular risk in patients with psoriasis. J Eur Acad Dermatol Venereol 2011 [Feb 23, Electronic publication ahead of print]. doi:10.1111\/j.1468-3083.2011.03982.x.","DOI":"10.1111\/j.1468-3083.2011.03982.x"},{"key":"10.1016\/j.autrev.2011.05.022_bb0285","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/HYPERTENSIONAHA.109.143982","article-title":"Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study","volume":"55","author":"Angel","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.autrev.2011.05.022_bb0290","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.autrev.2011.01.004","article-title":"Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment","volume":"10","author":"Solt\u00e9sz","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.022_bb0295","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.semarthrit.2006.09.001","article-title":"Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis","volume":"36","author":"Kimhi","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.05.022_bb0300","first-page":"877","article-title":"Subclinical atherosclerosis in psoriatic arthritis: a case control study","volume":"35","author":"Eder","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.05.022_bb0305","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/art.22530","article-title":"Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","volume":"57","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.05.022_bb0310","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/rheumatology\/ken090","article-title":"Cardiovascular risk profile of patients with psoriatic arthritis compared to controls\u2014the role of inflammation","volume":"47","author":"Tam","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2011.05.022_bb0315","first-page":"298","article-title":"Subclinical atherosclerosis in patients with psoriatic arthritis: a case\u2013control study. Preliminary data","author":"Contessa","year":"2009","journal-title":"Reumatismo"},{"issue":"108","key":"10.1016\/j.autrev.2011.05.022_bb0320","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.0000097113.11419.9E","article-title":"Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS)","volume":"11","author":"Williams","year":"2003","journal-title":"Circulation"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721100142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721100142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T02:03:41Z","timestamp":1560305021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721100142X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":64,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S156899721100142X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.05.022","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}